Pharma

London-based European specialist healthcare investor, GHO, and CBC Group, an Asian healthcare-focused asset manager, are merging to create the world’s largest dedicated healthcare investment...

Adragos Pharma, a Germany-based global CDMO, has appointed Konstantinos (Kostas) Rengis as its new CEO, succeeding company founder and CEO for the last six...

Lauxera Capital Partners has closed its second growth fund at €520m (US$605m), surpassing its €500m hard cap and nearly doubling the size of its...

Cheplapharm, a family-run pharmaceutical company headquartered in Germany, specialising in the development, marketing, and distribution of branded pharmaceutical products, is aligning its management board for the company’s next...

Water Street Healthcare Partners has held the first and final close of its sixth private equity fund at US$1.9bn. Fund VI was oversubscribed and...

Dirk Scholz has taken up his new role as CFO of the Sanner Group, a Germany-based global healthcare packaging and medical device CDMO. He succeeds...

Domitille de Vienne has joined France-based Andera Partners as a director within its MidCap team, focusing on private equity investments in France. She joins from...

CordenPharma, a Swiss-based full-service CDMO of APIs, lipid excipients, drug products and packaging, has appointed Marc Augustin as CFO. Augustin joins from PolyPeptide where he...

CellCentric, a clinical-stage biotechnology company, has completed an oversubscribed US$220m Series D financing led by Venrock Healthcare Capital Partners, with participation from Fidelity Management...

Angelini Pharma, the Italy-based international pharmaceutical company and part of the Angelini Industries Group, is entering the US market with the acquisition of Nasdaq-listed...